EUVIMEDEUVIMED entdecken
Crossref

Development and Optimization of Meloxicam-Loaded Microspheres for Enhanced Drug Delivery and Therapeutic Efficacy

Mrs. Shalini Vijay Rakhade, Dr. Dheeraj Dattatray Chechare, Ashwin Umendra Patle, Renuka Kapil Mahajan, Dr. Vamseekrishna Gorijavolu, Gayatri Katole, Mr. Rahul Lohan, Dr. Paresh Ashok Patil, Firos A

International Journal of Drug Delivery Technology · 30.04.2026 · 16 (23s)

DOI: 10.25258/ijddt.16.23s.36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.04.2026. Verfasst von Mrs. Shalini Vijay Rakhade und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to develop and optimize meloxicam-loaded microspheres to enhance drug delivery and therapeutic efficacy using a Quality by Design (QbD) approach coupled with Box–Behnken Design (BBD). Meloxicam, a poorly water-soluble non-steroidal anti-inflammatory drug, was encapsulated in poly (lactic-coglycolic acid) (PLGA)-based microspheres using the emulsion solvent evaporation method. The effects of critical formulation variables, including polymer concentration (X₁), drug-to-polymer ratio (X₂), and stabilizer concentration (X₃), were systematically evaluated on particle size, entrapment efficiency, and in vitro drug release. The optimized formulation exhibited a particle size of 161.4 ± 4.2 µm, entrapment efficiency of 80.9 ± 3.1%, and cumulative drug release of 73.2 ± 2.8% over the study period. Statistical analysis using ANOVA confirmed the significance of the quadratic model (p < 0.05) with a high coefficient of determination (R² > 0.98), indicating a strong correlation between predicted and observed values. Response surface analysis revealed that increasing polymer concentration enhanced entrapment efficiency and particle size, while reducing drug release, whereas higher stabilizer concentration contributed to improved particle uniformity. The optimized microspheres demonstrated sustained drug release behavior, suggesting their potential to improve oral bioavailability and reduce dosing frequency. The study highlights the effectiveness of the QbD-driven optimization approach in developing a robust and reproducible microsphere-based drug delivery system for meloxicam. Further in vivo studies are recommended to establish clinical applicability.

Zitieren

APA

Rakhade, M. S. V., Chechare, D. D. D., Patle, A. U., Mahajan, R. K., Gorijavolu, D. V., Katole, G., Lohan, M. R., Patil, D. P. A., & A, F. (2026). Development and Optimization of Meloxicam-Loaded Microspheres for Enhanced Drug Delivery and Therapeutic Efficacy. International Journal of Drug Delivery Technology, 16(23s). https://doi.org/10.25258/ijddt.16.23s.36

Vancouver

Rakhade MSV, Chechare DDD, Patle AU, Mahajan RK, Gorijavolu DV, Katole G, et al. Development and Optimization of Meloxicam-Loaded Microspheres for Enhanced Drug Delivery and Therapeutic Efficacy. International Journal of Drug Delivery Technology. 2026;16(23s). doi:10.25258/ijddt.16.23s.36

BibTeX
@article{Rakhade2026,
  author = {Rakhade, Mrs. Shalini Vijay and Chechare, Dr. Dheeraj Dattatray and Patle, Ashwin Umendra and Mahajan, Renuka Kapil and Gorijavolu, Dr. Vamseekrishna and Katole, Gayatri and Lohan, Mr. Rahul and Patil, Dr. Paresh Ashok and A, Firos},
  title = {Development and Optimization of Meloxicam-Loaded Microspheres for Enhanced Drug Delivery and Therapeutic Efficacy},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {23s},
  doi = {10.25258/ijddt.16.23s.36}
}
Kostenlos starten →